Supplementary Methods Purification and crystallization
Human OGT 4.5 was prepared as previously described 1 . Binary complex crystals were obtained by soaking apo crystals in reservoir solution containing 1 mM UDP-GlcNAc or UDP-5SGlcNAc 2 for 10 minutes. The apo crystals were grown by combining 2 µl OGT (7 mg/ml) with 1 µl of reservoir consisting of 1.9 M Ammonium Sulfate, 0.1M Tris pH 8.5 and 1% Xylitol. After soaking, crystals were cryoprotected in solution containing 2M Ammonium Sulfate, 0.05M Tris pH 8.5, and 27% Xylitol. Ternary complex crystals were prepared by first obtaining OGT-UDP-CKII ternary crystals, as previously described 1 . Ternary complexes were then prepared by incubating hOGT 4.5 (7 mg/ml) with 1 mM UDP-sugar (UDP-GlcNAc or UDP-5SGlcNAc) and 2 mM peptide (CKII or CKIIA). The OGT-UDP-CKII crystals were then used to seed the new ternary complex crystals using the Seed Bead Kit (Hampton). All peptides for crystallization and radioactive assays were purchased (Biomatik, ≥95% purity by HPLC and LC-MS)
Data collection, structure determination, and refinement
All data were collected at NSLS beamline X29 or X25 at Brookhaven National Laboratory. Data was processed using iMosflm 3 and scaled with Scala 4 . The previously determined OGT-UDP binary complex and OGT-UDP-CKII ternary complexes were used as search models for molecular replacement for the binary and ternary complexes, respectively, in this work, using Phaser 5 . The models were subsequently refined using Phenix 6 , with rigid body refinement and multiple rounds of simulated annealing, minimization, atomic displacement parameter (ADP or B-factor) refinement and TLS refinement (determined using the TLSMD server 7, 8 ) , with interspersed manual adjustments using Coot 9 . Geometric restraints for UDP-GlcNAc or UDP-5SGlcNAc were generating using Phenix Elbow 10 , and these restraints were used throughout refinement. All figures were made with Pymol, and hydrogens were added to the structure for the purpose of making figures, using Phenix Reduce 11 .
Activity assays
OGT activity with different UDP-sugars (UDP-GlcNAc, UDP-GalNAc, UDP-Glucose) was determined as previously reported using the radiometric peptide capture assay with the CKII peptide 12 and the corresponding UDP-[ 14 C]sugar (American Radiolabeled Chemicals). For determining the activity of OGT with a protein substrate and nonradiolabeled UDP-sugars, the activity was analyzed by SDS-PAGE (Coomassie stained) using nup62 as the acceptor. Nup62 was purified as previously reported 13 . All nonradioactive UDP-sugars (including UDP-GlcNAc for crystallization) were purchased from Sigma (≥98% purity), except for UDP-2-KetoGlucose, which was a kind gift from L. Cai 14 and was ≥98% pure upon receipt (MS).
2 h. The fully deprotected peptide was then filtered through a sintered glass frit, washed twice with fresh TFA and concentrated in vacuo using a high vacuum rotary evaporator. Purification of 5-carboxyfluoroscein native (5CF-AIPVSRAEK) and O-GlcNAc modified (5CF-AIPVS*RAEK) peptides The crude peptides (15 mg/run) were loaded onto an Agilent Zorbax 300SB--C8 (9.4 mm x 250 mm) semi--preparative HPLC column housed in an 1100 series Agilent HPLC. The peptide was purified using a linear gradient of 5% acetonitrile (ACN) to 40% ACN over 40 min operating at 2 mL/min. Fractions were collected using a Foxy Jr. fraction collector set to collect 0.666 mL fractions over the entirety of the HPLC run. The major peak eluted at approximately 13.6 min and was collected in fractions 40-42. These fractions were pooled and high--resolution mass spectrometry was carried out to verify the correct identity of the peptide. The purity of the peptides were estimated on the basis of HPLC and capillary electrophoresis analysis to be >95%. 
OGT kinetics assay
Kinetic assays were typically conducted in phosphate buffered saline (PBS), pH 7.4 (Lonza), in a final volume of 200 µL. 100 µM native peptide (5CF-AIPVSRAEK), 100 µM UDP-GlcNAc and 1 µM OGT were incubated for 30 min, and the reactions terminated by snap freezing in liquid nitrogen. For the reactions with UDP-5SGlcNAc, reactions were done in a final volume of 1 mL (to increase sensitivity for analysis), with the same concentrations of native peptide and OGT, and 100 µM UDP-5SGlcNAc. These reactions were incubated for 2 h, again to increase sensitivity for analysis. Samples were analyzed in triplicate. OGT was expressed and purified as described previously 17 . Following enzymatic reactions with OGT, O-GlcNAc or O-5SGlcNAc modified peptides were purified from native peptide by HPLC as described above for the synthetic peptides. A bacterial homologue of O-GlcNAcase, BtGH84, was used to cleave O-GlcNAc or O5SGlcNAc from the peptide; this was expressed and purified as described previously 18 . The purified peptides were incubated with BtGH84 in PBS overnight, and snap frozen until analysis.
OGT kinetics analysis by capillary electrophoresis
Samples were thawed and immediately applied to Sep-Pak (Waters) C18 solid-phase extraction cartridges which had been pre-conditioned by sequentially washing them with methanol (5 mL), 5% acetic acid (AcOH, 5 mL), 1-propanol (5 mL) and 5% AcOH (10 mL). Each Sep-Pak was washed with 2 x 1 mL 5% AcOH and peptides were eluted with 2 x 1 mL 20% 1-propanol containing 5% AcOH. Samples were lyophilized to dryness, redissolved in 200 µL 18 MΩ H 2 O, and aliquots were diluted 8-fold prior to capillary electrophoresis (CE) analysis on a ProteomeLab PA800 (Beckman-Coulter) by micellar electrokinetic chromatography (MEKC). Peptides were resolved under normal polarity in a 60 cm (to detector) x 50 µm (internal diameter) fused silica capillary using an applied voltage of 30 kV and a background electrolyte (BGE) consisting of boric acid (50 mM), sodium dodecyl sulphate (50 mM) and γ-cyclodextrin (11 mM), pH 9.0. The capillary was thermostated at 25 °C. Electrophoresis under these conditions typically produced a current of 40 µA. Samples were stored at 10 °C and injected at the anode by applying a pressure of 0.5 psi for 15 s. To ensure reproducible migration times the capillary was rinsed with 1 N NaOH (15 psi, 3 min), 18 MΩ H 2 O (15 psi, 3 min) and BGE (15 psi, 6 min), and the BGE was replaced after every second sample. Analytes were detected by measuring the fluorescence (488 nm excitation/520 nm emission) at a rate of 4 Hz, and peaks were integrated using 32 Karat Software version 7.0 (Beckman-Coulter). Data were plotted using OriginPro 8.0. A calibration curve, produced using serial dilutions of the synthetically prepared O-GlcNAc modified peptide (5CF-AIPVS*RAEK) standard, was constructed and ran on the same day as data were acquired for the OGT kinetic assays. Note that the glycopeptide formed using UDP-5SGlcNAc as a donor sugar comigrates with that formed using UDP-GlcNAc. 2 . It is used here to validate the identity of the O-5SGlcNAc glycopeptide. The OGT transfer reaction with UDP-5SGlcNAc as the donor sugar, HPLC purified O-5SGlcNAc glycopeptides, and a series of standards were analyzed by capillary electrophoresis. Some samples were digested using BtGH84, as previously described 18 , to demonstrate the presence of O-linked GlcNAc or 5SGlcNAc. Thus, these experiments demonstrated that UDP-5SGlcNAc is a 3200-fold worse substrate donor for OGT as compared to UDP-GlcNAc when assayed at equivalent concentrations.
Supplementary Results

Supplementary Figure 1
Supplementary Figure 3 Supplementary Figure 3 . The 5SGlcNAc analog is a mimic of the natural substrate. Overlay of the UDP-GlcNAc glycopeptide product complex (yellow) with the UDP-5SGlcNAc thioglycopeptide product complex (cyan), RMSD = 0.14 Å . The sulfur in the ring (black) does not greatly affect the conformation of the sugar. Importantly, the acetamide is in an identical conformation. * Highest-resolution shell is shown in parentheses. One crystal was used for each structure.
